ARTICLE | Company News
Mylan sales and marketing update
June 15, 2015 7:00 AM UTC
Mylan’s Mylan Pharmaceuticals Pvt. Ltd subsidiary launched MyHep, a generic version of 400 mg Sovaldi sofosbuvir from Gilead Sciences Inc. (NASDAQ:GILD, Foster City, Calif.), in India to treat chron...